Literature DB >> 17519559

Behavioral evaluation of male and female mice pups exposed to fluoxetine during pregnancy and lactation.

Sabrina F S Lisboa1, Paulo E Oliveira, Leandro C Costa, Emerson J Venâncio, Estefânia G Moreira.   

Abstract

BACKGROUND/AIMS: Fluoxetine (FLX) has been widely prescribed for depression during pregnancy and/or lactation. Since serotonin is a neurotrophic factor, the use of FLX by mothers could disrupt brain development resulting in behavioral alterations in their progeny. This study evaluated the effects of developmental FLX exposure on anxiety, depression, aggressivity and pain sensitivity of male and female mice pups.
METHODS: Swiss dams were treated daily, by gavage, with 7.5 mg/kg of FLX during pregnancy and lactation. Pups were submitted to open-field, forced swimming, elevated plus-maze, intruder-resident and hot plate tests at adolescence and adulthood. RESULTS AND
CONCLUSION: In male pups, exposure to FLX decreased ambulation at postnatal day (PND) 40 and tended (p=0.07) to increase the latency to the first attack in the intruder-resident test at PND 70, suggesting decreased impulsivity. In female pups, FLX exposure increased immobility time in the forced swimming test at both PND 30 and 70, which is interpreted as depressive-like behavior. In conclusion, our results suggest that maternal exposure to FLX during pregnancy and lactation results in enduring behavioral alterations in male and female pups throughout life. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17519559     DOI: 10.1159/000103097

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  32 in total

1.  Developmental influence of the serotonin transporter on the expression of npas4 and GABAergic markers: modulation by antidepressant treatment.

Authors:  Gianluigi Guidotti; Francesca Calabrese; Francesca Auletta; Jocelien Olivier; Giorgio Racagni; Judith Homberg; Marco A Riva
Journal:  Neuropsychopharmacology       Date:  2011-10-19       Impact factor: 7.853

Review 2.  Prenatal antidepressant exposure: clinical and preclinical findings.

Authors:  Chase H Bourke; Zachary N Stowe; Michael J Owens
Journal:  Pharmacol Rev       Date:  2014-02-24       Impact factor: 25.468

3.  Prenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates.

Authors:  Cécile Gurnot; Ignacio Martin-Subero; Sarah M Mah; Whitney Weikum; Sarah J Goodman; Ursula Brain; Janet F Werker; Michael S Kobor; Manel Esteller; Tim F Oberlander; Takao K Hensch
Journal:  Epigenetics       Date:  2015-04-18       Impact factor: 4.528

4.  Altered cerebellar organization and function in monoamine oxidase A hypomorphic mice.

Authors:  Loai Alzghoul; Marco Bortolato; Foteini Delis; Panayotis K Thanos; Ryan D Darling; Sean C Godar; Junlin Zhang; Samuel Grant; Gene-Jack Wang; Kimberly L Simpson; Kevin Chen; Nora D Volkow; Rick C S Lin; Jean C Shih
Journal:  Neuropharmacology       Date:  2012-08-16       Impact factor: 5.250

Review 5.  Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.

Authors:  Tamar L Gur; Deborah R Kim; C Neill Epperson
Journal:  Psychopharmacology (Berl)       Date:  2013-05-17       Impact factor: 4.530

6.  Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring.

Authors:  Jocelien D A Olivier; A Vallès; Floor van Heesch; Anthonieke Afrasiab-Middelman; Janneke J P M Roelofs; Marloes Jonkers; Elke Joan Peeters; Gerdien A H Korte-Bouws; Jos P Dederen; Amanda J Kiliaan; Gerard J Martens; Dirk Schubert; Judith R Homberg
Journal:  Psychopharmacology (Berl)       Date:  2011-04-14       Impact factor: 4.530

Review 7.  Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.

Authors:  Matthew E Glover; Sarah M Clinton
Journal:  Int J Dev Neurosci       Date:  2016-05-07       Impact factor: 2.457

8.  Fluoxetine exposure during adolescence alters responses to aversive stimuli in adulthood.

Authors:  Sergio D Iñiguez; Lyonna F Alcantara; Brandon L Warren; Lace M Riggs; Eric M Parise; Vincent Vialou; Katherine N Wright; Genesis Dayrit; Steven J Nieto; Matthew B Wilkinson; Mary K Lobo; Rachael L Neve; Eric J Nestler; Carlos A Bolaños-Guzmán
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

9.  Examining the Reversibility of Long-Term Behavioral Disruptions in Progeny of Maternal SSRI Exposure.

Authors:  Susan E Maloney; Shyam Akula; Michael A Rieger; Katherine B McCullough; Krystal Chandler; Adrian M Corbett; Audrey E McGowin; Joseph D Dougherty
Journal:  eNeuro       Date:  2018-07-09

10.  Neonatal fluoxetine exposure affects the neuronal structure in the somatosensory cortex and somatosensory-related behaviors in adolescent rats.

Authors:  Li-Jen Lee
Journal:  Neurotox Res       Date:  2009-03-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.